As of 2025-12-23, the Relative Valuation of Acceleron Pharma Inc (XLRN) is (71.75) USD. This relative valuation is based on P/E multiples. With the latest stock price at 178.75 USD, the upside of Acceleron Pharma Inc based on Relative Valuation is -140.1%.
The range of the Relative Valuation is (64.75) - (73.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 17.7x | 17.4x |
| Forward P/E multiples | 15.3x - 17.5x | 16.6x |
| Fair Price | (64.75) - (73.87) | (71.75) |
| Upside | -136.2% - -141.3% | -140.1% |
| Date | P/E |